Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Successful cancer control relies on overcoming resistance to cell death and on activation of host antitumor immunity. Oncolytic viruses are particularly attractive in this regard, as they lyse infected tumor cells and trigger robust immune responses during the infection. However, repeated injections...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Ther Oncolytics
Main Authors: Vähä-Koskela, Markus, Tähtinen, Siri, Grönberg-Vähä-Koskela, Susanna, Taipale, Kristian, Saha, Dipongkor, Merisalo-Soikkeli, Maiju, Ahonen, Marko, Rouvinen-Lagerström, Noora, Hirvinen, Mari, Veckman, Ville, Matikainen, Sampsa, Zhao, Fang, Pakarinen, Päivi, Salo, Jarmo, Kanerva, Anna, Cerullo, Vincenzo, Hemminki, Akseli
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782942/
https://ncbi.nlm.nih.gov/pubmed/27119097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2014.6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki